Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups.

Thumbnail
Name:
djr516.pdf
Size:
1.023Mb
Format:
PDF
Download
Authors
Urayama, Kevin Y
Jarrett, Ruth F
Hjalgrim, Henrik
Diepstra, Arjan
Kamatani, Yoichiro
Chabrier, Amelie
Gaborieau, Valerie
Boland, Anne
Nieters, Alexandra
Becker, Nikolaus
Foretova, Lenka
Benavente, Yolanda
Maynadié, Marc
Staines, Anthony
Shield, Lesley
Lake, Annette
Montgomery, Dorothy
Taylor, Malcolm
Smedby, Karin Ekström
Amini, Rose-Marie
Adami, Hans-Olov
Glimelius, Bengt
Feenstra, Bjarke
Nolte, Ilja M
Visser, Lydia
van Imhoff, Gustaaf W
Lightfoot, Tracy
Cocco, Pierluigi
Kiemeney, Lambertus
Vermeulen, Sita H
Holcatova, Ivana
Vatten, Lars
Macfarlane, Gary J
Thomson, Peter
Conway, David I
Benhamou, Simone
Agudo, Antonio
Healy, Claire M
Overvad, Kim
Tjønneland, Anne
Melin, Beatrice
Canzian, Federico
Khaw, Kay-Tee
Travis, Ruth C
Peeters, Petra H M
González, Carlos A
Quirós, José Ramón
Sánchez, María-José
Huerta, José María
Ardanaz, Eva
Dorronsoro, Miren
Clavel-Chapelon, Françoise
Bueno-de-Mesquita, H Bas
Riboli, Elio
Roman, Eve
Boffetta, Paolo
de Sanjosé, Silvia
Zelenika, Diana
Melbye, Mads
van den Berg, Anke
Lathrop, Mark
Brennan, Paul
McKay, James D
Affiliation
Genetics Section, International Agency for Research on Cancer, Lyon, France.
Issue Date
2012-02-08
MeSH
Aminopeptidases
Epstein-Barr Virus Infections
Genome-Wide Association Study
HLA-DR alpha-Chains
Herpesvirus 4, Human
Histocompatibility Antigens Class I
Hodgkin Disease
Humans
Logistic Models
Odds Ratio
Risk Factors

Metadata
Show full item record
Citation
Genome-wide association study of classical Hodgkin lymphoma and Epstein-Barr virus status-defined subgroups. 2012, 104 (3):240-53 J. Natl. Cancer Inst.
Publisher
Journal of the National Cancer Institute
Journal
Journal of the National Cancer Institute
URI
http://hdl.handle.net/10147/292523
DOI
10.1093/jnci/djr516
PubMed ID
22286212
Abstract
Accumulating evidence suggests that risk factors for classical Hodgkin lymphoma (cHL) differ by tumor Epstein-Barr virus (EBV) status. This potential etiological heterogeneity is not recognized in current disease classification.
Item Type
Article
Language
en
ISSN
1460-2105
Collections